We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
Cap. Flow
+$512M
Cap. Flow %
1.04%
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85

Sector Composition

Rank Sector Weight
1 Financials 16.9%
2 Technology 16.24%
3 Healthcare 13.01%
4 Industrials 10.83%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
I
2751
DELISTED
INTELSAT S. A.
I
$120K ﹤0.01%
35,410
-5,072
-13% -$22.6K
IVAC
2752
DELISTED
Intevac Inc
IVAC
$118K ﹤0.01%
17,202
-3,473
-17% -$26.7K
AREX
2753
DELISTED
Approach Resources Inc.
AREX
$118K ﹤0.01%
39,950
-7,688
-16% -$19K
CASC
2754
DELISTED
Cascadian Therapeutics, Inc.
CASC
$118K ﹤0.01%
31,890
-7,254
-19% -$29.7K
PMBC
2755
DELISTED
Pacific Mercantile Bancorp
PMBC
$117K ﹤0.01%
13,345
-2,513
-16% -$23.1K
ENT
2756
DELISTED
Global Eagle Entertainment Inc.
ENT
$117K ﹤0.01%
2,043
-337
-14% -$21.9K
VOXX
2757
DELISTED
VOXX International Corporation Class A
VOXX
$116K ﹤0.01%
20,739
-3,583
-15% -$23.4K
OSG
2758
DELISTED
Overseas Shipholding Group Inc.
OSG
$116K ﹤0.01%
42,498
-6,962
-14% -$18.1K
SCTL
2759
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$115K ﹤0.01%
13,887
-3,296
-19% -$27K
MCF
2760
DELISTED
Contango Oil & Gas Co.
MCF
$115K ﹤0.01%
24,381
-22,637
-48% -$86.6K
QTNT
2761
DELISTED
Quotient Limited Ordinary Shares
QTNT
$114K ﹤0.01%
574
-119
-17% -$22.9K
PCYO icon
2762
Pure Cycle
PCYO
$255M
$113K ﹤0.01%
13,580
-3,057
-18% -$23K
ARC
2763
DELISTED
ARC Document Solutions, Inc.
ARC
$109K ﹤0.01%
42,646
-7,144
-14% -$23.5K
AVXL icon
2764
Anavex Life Sciences
AVXL
$231M
$108K ﹤0.01%
33,547
-7,390
-18% -$29.1K
VRDN icon
2765
Viridian Therapeutics
VRDN
$2.2B
$106K ﹤0.01%
676
-153
-18% -$19.5K
RNAC icon
2766
Cartesian Therapeutics
RNAC
$218M
$105K ﹤0.01%
355
-59
-14% -$25.8K
TRAK icon
2767
ReposiTrak
TRAK
$160M
$105K ﹤0.01%
11,015
-1,900
-15% -$20.9K
IMH
2768
DELISTED
Impac Mortgage Holdings Inc.
IMH
$105K ﹤0.01%
10,348
-1,500
-13% -$18.1K
HSTO
2769
DELISTED
Histogen Inc. Common Stock
HSTO
$104K ﹤0.01%
113
-26
-19% -$24K
ADXS
2770
DELISTED
Advaxis Inc
ADXS
$102K ﹤0.01%
2,405
-486
-17% -$24.6K
TPHS
2771
DELISTED
Trinity Place Holdings Inc.com
TPHS
$101K ﹤0.01%
14,579
-4,042
-22% -$28.5K
LEAF
2772
DELISTED
Leaf Group Ltd.
LEAF
$101K ﹤0.01%
10,245
-100
-1% -$783
SYRS
2773
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$100K ﹤0.01%
1,026
-247
-19% -$33.2K
AAC
2774
DELISTED
AAC Holdings
AAC
$100K ﹤0.01%
11,148
-6,629
-37% -$59.8K
VSLR
2775
DELISTED
VIVINT SOLAR, INC.
VSLR
$99K ﹤0.01%
24,528
-4,653
-16% -$17.2K

Similar funds

RhumbLine Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
  • RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
  • RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
  • RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
  • RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.

Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.